Cardinal Health (CAH) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $253.71, +2.41% vs the prior close of $247.74.
- Volume 2.06M shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CAH rises 2.4% to $253.71, a 52-week high, 4 up days in a row. Closed at $253.71, +2.41% vs the prior close of $247.74. Day range $249.27–$254.00, opened at $252.00.
CAH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CAH rises 2.4% to $253.71, a 52-week high, 4 up days in a row
- Closed at $253.71, +2.41% vs the prior close of $247.74. Day range $249.27–$254.00, opened at $252.00.
- Volume was 2.06M shares, 1.2x its 50-day average of 1.75M.
- Price is +8.4% vs its 50-day average ($234.07) and +15.5% vs its 200-day average ($219.64).
- 52-week range $152.46–$258.30; today's close sits at 96% of that range, 1.8% below the 52-week high.
- That makes 4 straight gains.
Oct 14, 2026 — CAH jumps 3.3% to $247.74, a 1-month high, 3 up days in a row
- Closed at $247.74, +3.35% vs the prior close of $239.72. Day range $240.76–$247.93, opened at $240.90.
- Volume was 1.97M shares, 1.1x its 50-day average of 1.76M.
- Price is +6.0% vs its 50-day average ($233.78) and +12.9% vs its 200-day average ($219.40).
- 52-week range $151.87–$258.30; today's close sits at 90% of that range, 4.1% below the 52-week high.
- That makes 3 straight gains.
Oct 13, 2026 — CAH rises 0.7% to $239.72, a 1-month high
- Closed at $239.72, +0.69% vs the prior close of $238.08. Day range $236.19–$241.18, opened at $240.78.
- Volume was 1.35M shares, 0.8x its 50-day average of 1.78M.
- Price is +2.7% vs its 50-day average ($233.50) and +9.4% vs its 200-day average ($219.21).
- 52-week range $151.87–$258.30; today's close sits at 83% of that range, 7.2% below the 52-week high.
Oct 12, 2026 — CAH ends flat (+0.2%) to $238.08
- Closed at $238.08, +0.21% vs the prior close of $237.57. Day range $233.88–$240.10, opened at $238.93.
- Volume was 1.23M shares, 0.7x its 50-day average of 1.79M.
- Price is +2.0% vs its 50-day average ($233.41) and +8.7% vs its 200-day average ($219.05).
- 52-week range $151.87–$258.30; today's close sits at 81% of that range, 7.8% below the 52-week high.
Oct 9, 2026 — CAH dips 0.6% to $237.57
- Closed at $237.57, -0.58% vs the prior close of $238.96. Day range $236.37–$239.81, opened at $237.79.
- Volume was 1.03M shares, 0.6x its 50-day average of 1.80M — lighter than usual.
- Price is +1.9% vs its 50-day average ($233.25) and +8.5% vs its 200-day average ($218.89).
- 52-week range $151.87–$258.30; today's close sits at 81% of that range, 8.0% below the 52-week high.
Oct 8, 2026 — CAH rises 2.9% to $238.96
- Closed at $238.96, +2.93% vs the prior close of $232.16. Day range $231.25–$241.96, opened at $231.50.
- Volume was 1.54M shares, 0.8x its 50-day average of 1.82M.
- Price is +2.5% vs its 50-day average ($233.04) and +9.2% vs its 200-day average ($218.73).
- 52-week range $151.87–$258.30; today's close sits at 82% of that range, 7.5% below the 52-week high.
Oct 7, 2026 — CAH dips 0.5% to $232.16
- Closed at $232.16, -0.55% vs the prior close of $233.44. Day range $230.61–$235.97, opened at $233.61.
- Volume was 1.10M shares, 0.6x its 50-day average of 1.85M — lighter than usual.
- Price is -0.3% vs its 50-day average ($232.85) and +6.2% vs its 200-day average ($218.55).
- 52-week range $151.87–$258.30; today's close sits at 75% of that range, 10.1% below the 52-week high.
Oct 6, 2026 — CAH ends flat (+0.1%) to $233.44
- Closed at $233.44, +0.14% vs the prior close of $233.12. Day range $231.64–$235.19, opened at $233.69.
- Volume was 1.15M shares, 0.6x its 50-day average of 1.85M.
- Price is +0.3% vs its 50-day average ($232.85) and +6.9% vs its 200-day average ($218.38).
- 52-week range $151.87–$258.30; today's close sits at 77% of that range, 9.6% below the 52-week high.
Oct 5, 2026 — CAH rises 2.1% to $233.12
- Closed at $233.12, +2.11% vs the prior close of $228.30. Day range $228.59–$234.18, opened at $229.11.
- Volume was 1.72M shares, 0.9x its 50-day average of 1.85M.
- Price is +0.1% vs its 50-day average ($232.77) and +6.8% vs its 200-day average ($218.21).
- 52-week range $150.78–$258.30; today's close sits at 77% of that range, 9.7% below the 52-week high.
Oct 2, 2026 — CAH dips 0.8% to $228.30
- Closed at $228.30, -0.78% vs the prior close of $230.09. Day range $224.45–$231.10, opened at $229.54.
- Volume was 1.86M shares, 1.0x its 50-day average of 1.84M.
- Price is -1.9% vs its 50-day average ($232.67) and +4.7% vs its 200-day average ($218.03).
- 52-week range $150.78–$258.30; today's close sits at 72% of that range, 11.6% below the 52-week high.
CAH latest news & SEC filings
Every SEC filing by or about CAH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 21, 2026 · ARS — Annual report to shareholders
Annual report to shareholders
Sep 21, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Sep 21, 2026 · DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Scherer Mary C. sold 2,202 shares at $237.39 (≈$522.73K) on Aug 19, 2026
- Scherer Mary C. sold 100 shares at $237.40 (≈$23.74K) on Aug 19, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hollar Jason M. sold 6,244 shares at $237.88 (≈$1.49M) on Aug 19, 2026
- Hollar Jason M. sold 16,187 shares at $237.23 (≈$3.84M) on Aug 19, 2026
- Hollar Jason M. sold 6,731 shares at $236.46 (≈$1.59M) on Aug 19, 2026
- Hollar Jason M. sold 5,704 shares at $235.34 (≈$1.34M) on Aug 19, 2026
- Hollar Jason M. sold 3,457 shares at $234.29 (≈$809.94K) on Aug 19, 2026
- Hollar Jason M. sold 6,206 shares at $233.22 (≈$1.45M) on Aug 19, 2026
- …plus 4 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Weitzman Deborah sold 281 shares at $237.44 (≈$66.72K) on Aug 18, 2026
- Weitzman Deborah sold 6,665 shares at $235.30 (≈$1.57M) on Aug 18, 2026
- Weitzman Deborah sold 408 shares at $236.59 (≈$96.53K) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Alt Aaron E sold 13,685 shares at $236.58 (≈$3.24M) on Aug 18, 2026
- Alt Aaron E sold 12,228 shares at $235.54 (≈$2.88M) on Aug 18, 2026
- Alt Aaron E sold 3,115 shares at $234.55 (≈$730.62K) on Aug 18, 2026
- Alt Aaron E sold 12,972 shares at $237.26 (≈$3.08M) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mayer Jessica L sold 3,900 shares at $234.64 (≈$915.10K) on Aug 18, 2026
- Mayer Jessica L sold 10,246 shares at $235.51 (≈$2.41M) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · 10-K — Annual report (audited full-year financial statements and business review)
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $254.25B (prior year $222.58B) (+14.2% vs Jun 30, 2025)
- Net income: $1.71B (prior year $1.56B) (+9.8% vs Jun 30, 2025)
- Diluted EPS: $7.23 (prior year $6.45) (+12.1% vs Jun 30, 2025)
Aug 11, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 11, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 1.02 — Ended a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade CAH
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 5, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.19% (largest 3.4%).
- Liquidity: about 1.86M shares (≈$470.98M) trade per day on average.
- 52-week position: $253.71 vs a range of $152.46–$258.30 (96% of the range).
- Dividends: last ex-dividend date Oct 1, 2026 ($0.516/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Mary C. Scherer sold 2,202 shares on Aug 19, 2026.
- Latest filings: 8-K Oct 1, 2026; 10-K Aug 11, 2026; 8-K Aug 11, 2026.
- Share count: 232.58M shares outstanding (Jul 31, 2026), -2.6% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries.
CAH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 252.00 | 254.00 | 249.27 | 253.71 | 2.06M |
| Oct 14, 2026 | 240.90 | 247.93 | 240.76 | 247.74 | 1.97M |
| Oct 13, 2026 | 240.78 | 241.18 | 236.19 | 239.72 | 1.35M |
| Oct 12, 2026 | 238.93 | 240.10 | 233.88 | 238.08 | 1.23M |
| Oct 9, 2026 | 237.79 | 239.81 | 236.37 | 237.57 | 1.03M |
| Oct 8, 2026 | 231.50 | 241.96 | 231.25 | 238.96 | 1.54M |
| Oct 7, 2026 | 233.61 | 235.97 | 230.61 | 232.16 | 1.10M |
| Oct 6, 2026 | 233.69 | 235.19 | 231.64 | 233.44 | 1.15M |
| Oct 5, 2026 | 229.11 | 234.18 | 228.59 | 233.12 | 1.72M |
| Oct 2, 2026 | 229.54 | 231.10 | 224.45 | 228.30 | 1.86M |
| Oct 1, 2026 | 227.55 | 235.95 | 227.40 | 230.09 | 1.91M |
| Sep 30, 2026 | 223.66 | 226.49 | 222.07 | 222.50 | 1.94M |
| Sep 29, 2026 | 218.54 | 224.01 | 216.70 | 223.91 | 973.60K |
| Sep 28, 2026 | 219.37 | 221.97 | 218.90 | 220.29 | 2.39M |
| Sep 25, 2026 | 222.00 | 223.02 | 219.10 | 220.22 | 2.09M |
| Sep 24, 2026 | 222.08 | 225.37 | 221.95 | 222.62 | 3.48M |
| Sep 23, 2026 | 221.79 | 225.64 | 220.94 | 221.27 | 1.22M |
| Sep 22, 2026 | 227.17 | 228.44 | 221.21 | 222.04 | 2.78M |
| Sep 21, 2026 | 225.28 | 227.58 | 223.54 | 225.75 | 1.19M |
| Sep 18, 2026 | 225.29 | 226.12 | 221.70 | 225.38 | 4.14M |
About Cardinal Health
Cardinal Health (CAH) is listed on the NYSE and classified by the SEC under “Wholesale-Drugs, Proprietaries & Druggists' Sundries”. Its business address is in DUBLIN, OH. State of incorporation: OH. Fiscal year ends June 30. SEC CIK 721371.
CAH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert Azelby | Director | Nov 6, 2025 |
| Michelle Brennan | Director | Nov 6, 2025 |
| Sheri H. Edison | Director | Nov 6, 2025 |
| David C Evans | Director | Nov 6, 2025 |
| Patricia Hemingway Hall | Director | Apr 17, 2026 |
| Akhil Johri | Director | Nov 6, 2025 |
| Gregory B Kenny | Director | Nov 6, 2025 |
| Nancy Killefer | Director | Nov 6, 2025 |
| Christine Mundkur | Director | Nov 6, 2025 |
| Robert W Musslewhite | Director | Nov 6, 2025 |
| Sudhakar Ramakrishna | Director | Nov 6, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Aaron E Alt | Chief Financial Officer | Aug 20, 2026 |
| Michelle D. Greene | Chief Information Officer | Aug 20, 2026 |
| Jason M. Hollar | Chief Executive Officer | Aug 20, 2026 |
| Stephen M Mason | CEO, GMPD Segment | Aug 20, 2026 |
| Jessica L Mayer | Chief Legal/Compliance Officer | Aug 20, 2026 |
| Valerie Christine Pitteroff | Chief Human Resources Officer | Aug 18, 2026 |
| Mary C. Scherer | Chief Accounting Officer | Aug 20, 2026 |
| Ola M Snow | Chief Human Resources Officer | Dec 2, 2025 |
| Deborah Weitzman | CEO, PSS Segment | Aug 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | Mary C. Scherer | Sale | 2,202 | $237.39 |
| Aug 19, 2026 | Mary C. Scherer | Sale | 100 | $237.40 |
| Aug 19, 2026 | Jason M. Hollar | Sale | 6,244 | $237.88 |
| Aug 19, 2026 | Jason M. Hollar | Sale | 16,187 | $237.23 |
| Aug 19, 2026 | Jason M. Hollar | Sale | 6,731 | $236.46 |
| Aug 19, 2026 | Jason M. Hollar | Sale | 5,704 | $235.34 |
| Aug 19, 2026 | Jason M. Hollar | Sale | 3,457 | $234.29 |
| Aug 19, 2026 | Jason M. Hollar | Sale | 6,206 | $233.22 |
| Aug 18, 2026 | Aaron E Alt | Sale | 13,685 | $236.58 |
| Aug 18, 2026 | Aaron E Alt | Sale | 12,228 | $235.54 |
| Aug 18, 2026 | Aaron E Alt | Sale | 3,115 | $234.55 |
| Aug 18, 2026 | Aaron E Alt | Sale | 12,972 | $237.26 |
| Aug 18, 2026 | Jason M. Hollar | Sale | 16,208 | $236.54 |
| Aug 18, 2026 | Jason M. Hollar | Sale | 12,470 | $237.25 |
| Aug 18, 2026 | Jason M. Hollar | Sale | 29,915 | $235.51 |
CAH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $254.25B | $1.71B | 7.23 | $5.17B |
| Jun 30, 2025 | $222.58B | $1.56B | 6.45 | $2.40B |
| Jun 30, 2024 | $226.83B | $852.00M | 3.45 | $3.76B |
| Jun 30, 2023 | $204.98B | $330.00M | 1.26 | $2.84B |
| Jun 30, 2022 | $181.33B | $-938.00M | -3.37 | $3.17B |
Latest balance sheet: total assets $57.30B, total liabilities $—, cash $4.86B (as of Jun 30, 2026).
CAH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $240.26 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $192.88 |
| Feb 5, 2026 | 8-K Item 2.02 (results) | $227.18 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $189.84 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $146.30 |
| May 1, 2025 | 8-K Item 2.02 (results) | $145.53 |
| Jan 30, 2025 | 8-K Item 2.02 (results) | $128.26 |
| Nov 1, 2024 | 8-K Item 2.02 (results) | $116.13 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 1, 2024 | 8-K Item 2.02 (results) | — |
| Jan 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Mckesson (MCK)Cencora (COR)Herbalife (HLF)Nu Skin Enterprises (NUS)Cosmos Health (COSM)DataMeds AI (MEDS)Cellyan Biotechnology (HKPD)HWH International (ESYN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CAH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.